Bill Snyder

March 15, 2018

MIT’s Wittrup set for March 22 Flexner Discovery Lecture

K. Dane Wittrup, PhD, a pioneer in protein engineering technologies who has helped accelerate development of antibody therapies for cancer, will deliver the next Flexner Discovery Lecture on Thursday, March 22.

By Bill Snyder
close up of mans arm as he receives chemotherapy infusion
March 14, 2018

Boehringer Ingelheim and Vanderbilt University expand partnership to develop novel treatment approaches for cancer

New agreement will pursue therapies targeting MCL1 (myeloid cell leukemia 1), which is highly prevalent in many difficult-to-treat cancers.

By Bill Snyder
ekg results
March 12, 2018

Long QT syndrome – revealed

Vanderbilt investigators have used sophisticated cell biological and structural techniques to “classify” mutations in potassium channels, studies that could lead to personalized treatment of heart rhythm disorders.

By Bill Snyder
March 6, 2018

Discovery by Vanderbilt-led group could lead to improved diabetes treatment

Vanderbilt investigators and colleagues around the country have made a major discovery that could lead to better ways to treat type 1 diabetes (T1D).

By Bill Snyder
neuron
March 1, 2018

Graphene material strengthens nerve signaling in the brain

Less than 20 years after it was developed, a thin, resilient sheet of carbon atoms with remarkable properties known as graphene is transforming biomedical fields as far flung as tissue engineering, neuroprosthetics and drug discovery.

By Bill Snyder
February 23, 2018

Hope for an RSV vaccine

Newly discovered features in an RSV protein may be useful for rational structure-based vaccine design.

By Bill Snyder
February 22, 2018

Brain Awareness events highlight mind’s wonders

Research on circadian rhythms, longevity and the brain’s pleasure system will be featured during this year’s Brain Awareness events sponsored by the Vanderbilt Brain Institute.
By Bill Snyder
February 15, 2018

Vanderbilt’s Gamazon named visiting fellow at Cambridge University

Eric Gamazon, PhD, research instructor in the Division of Genetic Medicine at Vanderbilt University School of Medicine, is spending part of the academic year at Cambridge University in England as one of 40 Clare Hall Visiting Fellows.
By Bill Snyder
February 15, 2018

Noted neuroscientist Gouaux set for Discovery Lecture

Eric Gouaux, PhD, whose work has helped reveal the molecular mechanisms by which nerve cells communicate, will deliver the next Flexner Discovery Lecture Thursday, Feb. 22.
By Bill Snyder
February 8, 2018

Event showcases REDCap’s data management versatility

Fourteen years after it was launched, REDCap, Vanderbilt University’s research data management tool, has transformed clinical and translational studies around the globe.
By Bill Snyder
February 8, 2018

Study helps map signaling system in brain linked to ASD

Researchers at Vanderbilt University have worked out part of the “wiring diagram” of a signaling system in the brain that has been linked to autism spectrum disorder (ASD).
By Bill Snyder
February 8, 2018

Partnership enhances eye care for Ebola survivors in Liberia

Vanderbilt University School of Medicine (VUSM), the Vanderbilt Institute for Global Health (VIGH) and the Vanderbilt Eye Institute (VEI) have joined forces with partners in Liberia to strengthen medical education and increase access to ophthalmology care in the aftermath of the 2014-2015 West African Ebola epidemic that killed more than 11,000 people.
By Bill Snyder
1 … 55 56 57 58 59 … 110